Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA 15206, USA.
UPMC Hillman Cancer Center, Pittsburgh, PA 15213, USA.
Nucleic Acids Res. 2021 Sep 27;49(17):9633-9647. doi: 10.1093/nar/gkab745.
The identity and functions of specialized cell types are dependent on the complex interplay between signaling and transcriptional networks. Recently single-cell technologies have been developed that enable simultaneous quantitative analysis of cell-surface receptor expression with transcriptional states. To date, these datasets have not been used to systematically develop cell-context-specific maps of the interface between signaling and transcriptional regulators orchestrating cellular identity and function. We present SPaRTAN (Single-cell Proteomic and RNA based Transcription factor Activity Network), a computational method to link cell-surface receptors to transcription factors (TFs) by exploiting cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) datasets with cis-regulatory information. SPaRTAN is applied to immune cell types in the blood to predict the coupling of signaling receptors with cell context-specific TFs. Selected predictions are validated by prior knowledge and flow cytometry analyses. SPaRTAN is then used to predict the signaling coupled TF states of tumor infiltrating CD8+ T cells in malignant peritoneal and pleural mesotheliomas. SPaRTAN enhances the utility of CITE-seq datasets to uncover TF and cell-surface receptor relationships in diverse cellular states.
细胞类型的特征和功能取决于信号转导和转录网络之间的复杂相互作用。最近开发的单细胞技术能够同时定量分析细胞表面受体表达与转录状态。迄今为止,这些数据集尚未用于系统地开发协调细胞特征和功能的信号转导和转录调控因子之间界面的特定于细胞环境的图谱。我们提出了 SPaRTAN(基于单细胞蛋白质组学和 RNA 的转录因子活性网络),这是一种通过利用细胞转录组和表位测序(CITE-seq)数据集与顺式调控信息进行细胞索引的方法,将细胞表面受体与转录因子 (TF) 联系起来的计算方法。SPaRTAN 应用于血液中的免疫细胞类型,以预测信号受体与细胞环境特异性 TF 的偶联。通过先验知识和流式细胞术分析验证选定的预测结果。然后,SPaRTAN 用于预测恶性腹膜和胸膜间皮瘤中肿瘤浸润性 CD8+T 细胞的信号偶联 TF 状态。SPaRTAN 增强了 CITE-seq 数据集的实用性,可用于揭示不同细胞状态下 TF 和细胞表面受体之间的关系。